Pain News and Research

Latest Pain News and Research

Researchers discover new procedure for treatment of uterine fibroids

Jersey Shore University Medical Center announces today that Mark Martens, M.D., chief of Obstetrics and Gynecology, performed the first Acessa procedure in New Jersey. The procedure is used for the treatment of uterine fibroids. Additionally, Jersey Shore's Jocelyn A. Carlo, M.D., Obstetrics/Gynecology, is performing the procedure.

1 Oct 2013

TSRI scientist wins prestigious New Innovator Award from NIH

A scientist on the Florida campus of The Scripps Research Institute has won a prestigious New Innovator Award from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH).

1 Oct 2013

AcelRx Pharmaceuticals submits Zalviso NDA to FDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it submitted a New Drug Application to the U.S. Food and Drug Administration for Zalviso (sufentanil sublingual microtablet system).

30 Sep 2013

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Minimally invasive treatments for lumbar spinal stenosis: an interview with James Corbett, President & Chief Executive Officer of Vertos Medical

Lumbar spinal stenosis (LSS) is a degenerative, age-related narrowing of the lower spinal canal that causes pressure on the nerves, leading to pain and reduced mobility. Symptoms include pain, numbness, or tingling in the lower back, legs, or buttocks, which limits your ability to stand or walk.

30 Sep 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

College of American Pathologists awards accreditation to Ameritox

Ameritox has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) for a second time, based on the results of recent onsite inspections of its laboratories.

27 Sep 2013

Women should tackle hormonal chaos, seek treatment for perimenopausal symptoms

Women should address the "hormonal chaos" of their 40s and not be afraid to seek treatment for perimenopausal symptoms, advises an internationally recognized expert in reproductive endocrinology from Wake Forest Baptist Medical Center.

27 Sep 2013

Longer looks: Dangers of too much Tylenol; emergency contraception for Native Americans; death dinners

During the last decade, more than 1,500 Americans died after accidentally taking too much of a drug renowned for its safety: acetaminophen, one of the nation's most popular pain relievers. Acetaminophen – the active ingredient in Tylenol – is considered safe when taken at recommended doses. Tens of millions of people use it weekly with no ill effect. But in larger amounts, especially in combination with alcohol, the drug can damage or even destroy the liver (Jeff Gerth and T. Christian Miller, 9/20).

27 Sep 2013

Icotinib matches gefitinib in NSCLC second or third line

Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.

26 Sep 2013

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.

26 Sep 2013

VeriMed secures $3 million in venture funding

VeriMed, a technology company that works to provide a secure, transparent and safe supply chain for controlled substances, today announced it has secured $3 million in venture funding. The financing was led by Fortis Capital Holdings, a private investment firm.

25 Sep 2013

Clinical decision rule may help doctors identify patients with headache in emergency department

Researchers have developed a simple clinical decision rule that may help doctors identify patients with headache in the emergency department who have subarachnoid hemorrhage (bleeding in a certain area of the brain), according to a study in the September 25 issue of JAMA.

25 Sep 2013

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.

25 Sep 2013

Fat grafting shows promise as effective treatment for scars

Millions of people with scars suffer from pain, discomfort, and inability to perform regular activities. Some may have to revert to addicting pain medicine to get rid of their ailments.

25 Sep 2013

Exercise and diet led to less knee pain for adults with knee osteoarthritis

Among overweight and obese adults with knee osteoarthritis, combining intensive diet and exercise led to less knee pain and better function after 18 months than diet-alone and exercise-alone, according to a study in the September 25 issue of JAMA.

25 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

NeoTract treats first patient in US with UroLift System

NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013